BeStock  
Stocks › Biotechnology › ABCL

AbCellera Biologics ABCL

US equityMarket cap rank #2395BiotechnologyAI medical concept stocks
$9.69 −$0.78 (-7.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.73 +0.41%
Open$10.14
Prev close$10.47
Day range$9.58 – $10.26
Volume4.25M
Market cap$3.16B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±6.3%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+10.3%
Worst reaction-13.7%

Stock move on the day after each report

-9.4%2023/Q4-5.0%2024/Q1-7.7%2024/Q2-5.9%2024/Q3-11.5%2024/Q4+1.0%2025/Q1+0.2%2025/Q2-13.7%2025/Q3-0.9%2025/Q4-5.7%2026/Q1+10.3%2026/Q2-0.3%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q39 Nov 2026After Market±12.9%-0.32%Within range
2026/Q25 Aug 2026After Market±18.1%+10.30%Within range
2026/Q111 May 2026After Market±12.9%-5.71%Within range
2025/Q424 Feb 2026After Market±22.4%-0.93%Within range
2025/Q36 Nov 2025After Market±18.5%-13.69%Within range
2025/Q27 Aug 2025After Market±26.2%+0.24%Within range
2025/Q18 May 2025After Market±35.1%+1.00%Within range
2024/Q427 Feb 2025After Market±30.8%-11.47%Within range
2024/Q34 Nov 2024After Market±19.3%-5.88%Within range
2024/Q26 Aug 2024After Market±15.8%-7.72%Within range
2024/Q17 May 2024After Market±19.4%-4.95%Within range
2023/Q420 Feb 2024After Market±19.6%-9.42%Within range
2023/Q32 Nov 2023After Market±19.3%+6.09%Within range
2023/Q23 Aug 2023After Market±17.8%-13.34%Within range
2023/Q14 May 2023After Market±18.2%-9.38%Within range
2022/Q421 Feb 2023After Market±18.3%-1.12%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By region

  • Canada$64.00M 85.2%
  • United States$11.10M 14.8%

Latest reported quarter: Q3, ended Sep 2026

Revenue$10.64M+18.8% YoY
Operating profit-$49.68M+32.5% YoY
Net profit-$40.76M+28.6% YoY
Diluted EPS-$0.13+31.6% YoY
Free cash flow$25.30M+141.1% YoY
Operating cash flow$26.91M

Revenue, last 8 quarters

$5.1MDec '24$4.2MMar '25$17.1MJun '25$9.0MSep '25$44.9MDec '25$8.3MMar '26$4.1MJun '26$10.6MSep '26

Net profit, last 8 quarters

$-34.2MDec '24$-45.6MMar '25$-34.7MJun '25$-57.1MSep '25$-8.9MDec '25$-43.2MMar '26$-55.4MJun '26$-40.8MSep '26

Profitability & balance sheet

Operating margin-275.7%
Net margin-218.6%
Return on equity-14.6%
Return on assets-10.4%
Return on invested capital-14.3%
Current ratio12.43
Liabilities / assets29.2%
Cash & investments$764.42M
Total debt$128.13M
Net cash (debt)$636.29M

Discussion

No comments yet — be the first to weigh in on ABCL.

Sign in to join the discussion.

Scroll to Top